Aspergiloma primário e aspergilose invasiva subaguda em dois pacientes com AIDS by Martinez, Roberto et al.
Rev. Inst. Med. trop. S. Paulo
51(1):49-52, January-February, 2009
doi: 10.1590/S0036-46652009000100009
(1) Division of Infectious and Tropical Diseases, Department of Clinical Medicine, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Brazil.
(2) Department of Clinical Medicine, University Hospital, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Brazil.
Correspondence to: Roberto Martinez, MD, Departamento de Clínica Médica, Faculdade de Medicina de Ribeirão Preto/USP, Av. dos Bandeirantes 3900, 14048-900 Ribeirão Preto, SP, 
Brasil. E-mail: rmartine@fmrp.usp.br 
CASE REPORT
PRIMARY ASPERGILLOMA AND SUBACUTE INVASIVE ASPERGILLOSIS IN TWO AIDS PATIENTS
Roberto MARTINEZ(1), Gleusa de CASTRO(2), Alcyone A. MACHADO(1) & Maria Janete MOYA (2)
SUMMARY
Although uncommon, invasive aspergillosis in the setting of AIDS is important because of its peculiar clinical presentation and 
high lethality. This report examines two AIDS patients with a history of severe cellular immunosuppression and previous neutropenia, 
who developed subacute invasive aspergillosis. One female patient developed primary lung aspergilloma, with dissemination to the 
mediastinum, vertebrae, and spine, which was fatal despite antifungal treatment. The second patient, who had multiple cavitary brain 
lesions, and eye and lung involvement, recovered following voriconazole and itraconazole, and drugs for increasing neutrophil and 
CD4+ lymphocyte levels. These cases demonstrate the importance of Aspergillus infections following neutropenia in AIDS patients, 
and emphasize the need for early and effective antifungal therapy.
KEYWORDS: Aspergilloma; Acquired immunodeficiency syndrome; Central nervous system; Invasive aspergillosis; 
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INTRODUCTION
Aspergillus species can be cause of different lung diseases, including 
allergic bronchopulmonary aspergillosis, aspergilloma, chronic invasive 
pulmonary infection, and acute invasive infection. Immunocompromised 
patients are more susceptible to invasive Aspergillus disease. This is 
particularly true for patients with neutropenia, reduced neutrophil activity, 
reduced hematopoietic stem cells, and those with a history of solid 
organ transplantation, corticosteroid therapy, or cytotoxic chemotherapy. 
Although infrequent in HIV-infected patients (0 to 12% prevalence 
at autopsy), the disease is highly lethal in advanced AIDS3,5. In HIV-
infected patients, Aspergillus pulmonary lesions are characterized by 
interstitial or alveolar infiltrates, nodules, cavities, abscesses, hemorrhagic 
infarction, or pleural discharge6,18. The central nervous system may also 
be secondarily involved in AIDS patients7,16,24. Invasive aspergillosis less 
frequently involves the sinuses, orbit, eye, heart or other viscera8,13,17,19,25. 
Primary cutaneous lesions2,14 and isolated tracheobronchitis23 have been 
reported. A previous study reported aspergillosis diagnosed between 10 
and 26 months following onset of AIDS; despite anti-fungal therapy, 
these patients died within two to four months6.
This case series describes two patients who developed subacute 
invasive Aspergillus infection in the setting of AIDS, one in the form of 
invasive pulmonary mycetoma and the other as a primary opportunistic 
disease. 
CASE REPORTS
Case 1: The patient was a 33-year-old housewife diagnosed with HIV 
in 1997. She refused antiretroviral treatment at this time. In September 
1999, the patient developed pneumonia and was subsequently treated 
with zidovudine, lamivudine and indinavir, as well as trimethoprim/
sulfamethoxazole for Pneumocystis jiroveci prophylaxis (105 CD4 cells/
µL). Trimethoprim/sulfamethoxazole was discontinued and stavudine 
substituted for zidovudine in January 2000 because the patient developed 
anemia and leukopenia (572 neutrophils/µL) in the last two months. 
In June 2000, the antiretroviral regimen was changed to didanosine, 
lamivudine and nelfinavir after the patient developed sinusitis, oral 
candidiasis, and esophageal candidiasis. 
In September 2000, the patient developed a productive cough, 
and a chest x-ray showed a right upper lung lobe cavitation. Although 
microscopy did not demonstrate acid fast bacilli, the patient was 
presumptively treated for tuberculosis with rifampicin, isoniazid and 
pyrazinamide. Antiretrovirals were withheld during this time. 
Two months later, her symptoms persisted and she had lost two 
kilograms. Her neutrophil count had increased to 1512 cells/µL, and chest 
x-ray and computed tomography (CT) showed a cavity with a fungus ball 
inside, compatible with a pulmonary mycetoma. Repeated microscopic 
examination and sputum culture were negative for mycobacteria 
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but positive for Aspergillus fumigatus. The patient’s antibodies anti-
Aspergillus titer was 1:64. Itraconazole 400 mg PO, daily, was added, 
and an antiretroviral regimen of zidovudine, lamivudine, saquinavir and 
ritonavir was started. 
In April 2001, the patient weighed 40 kg, and complained of a 
persistent cough, foul-smelling sputum, fever, and pain in the right upper 
chest. HIV1 viral load was 220,000 copies/µL, and CD4+ count was 18 
cells/µL. The inflammatory infiltrate had involved the entire right upper 
lung lobe (Fig. 1a) and a new CT showed a large aspergilloma with air 
crescent sign and invasion of the surrounding lung parenchyma (Fig. 
1b). A. fumigatus was isolated from the sputum, and anti-Aspergillus 
titers remained at 1:64. 
The patient received ceftriaxone and amphotericin B deoxycholate 
(2,200 mg) for presumed invasive aspergillosis with secondary bacterial 
infection and underwent surgical resection of the right upper lung lobe. 
Histologic analysis of lobectomy material revealed a granulomatous 
chronic inflammatory process, presence of Aspergillus hyphae, and 
cytological alterations suggestive of cytomegalovirus. The patient 
recovered following surgery and felt well until August 2001, when she 
developed a productive cough, chest pain and tachypnea.
In the following weeks, the patient presented with lower limb 
paresthesia, paraparesis, and urinary incontinence. Soon thereafter her 
condition deteriorated and she developed pneumonia. A. fumigatus was 
identified in many sputum cultures. A CT of the thorax showed bilateral 
reticulonodular infiltrates with mediastinal lymphadenopathy (Fig. 2a). 
Magnetic resonance imaging (MRI) of the spine revealed T4 to T6 
vertebral and intervertebral disk destruction, with spinal cord involvement 
(Fig. 2b). Despite receiving another course of amphotericin B (340 mg), 
the patient died in October 2001.
Case 2: The patient was a 32-year-old male pharmacist who had 
been without medical care since his HIV diagnosis one year prior. For 
four months prior to presentation, he experienced behavioral changes, 
including forgetfulness and irritability. A head CT showed hypodense 
non-enhancing lesions, and presumptive treatment for cerebral 
toxoplasmosis was started. After 25 days of treatment, the patient showed 
no evidence of clinical or radiologic improvement. A stereotactic brain 
biopsy showed white matter demyelination, suggestive of progressive 
multifocal leukoencephalopathy. Treatment with corticosteroids, 
zidovudine, lamivudine, lopinavir/ritonavir, dexamethasone and 
carbamazepine was initiated. 
In December 2006, eight months after onset of symptoms, the patient 
was admitted in São Paulo University Hospital at Ribeirão Preto, SP. 
Behavioral alterations persisted and he had a 20-day history of left-eye 
hyperemia and purulent discharge. On exam, the patient was confused, 
with left palpebral ptosis and oral candidiasis. At admission, laboratory 
data were as follows: hemoglobin 6.6 g/dL; leukocytes 1500 cells/µL; 
800 neutrophils/ µL; 194,000 platelets/µL; and alanine aminotransferase 
49 UI/L. The level of the HIV1 viral load was less than 50 copies/mL and 
the CD4+ count was 84 cells/µL. Intraocular puncture yielded vitreous 
material containing Aspergillus. A CT of the thorax showed a thick-walled 
cavity with peripheral aspergilloma in the right upper lobe (Fig. 3a). An 
MRI of the brain showed cavitary lesions in the left frontal, left parietal, 
left temporal, and right parieto-occipital lobes, as well as endophthalmitis 
in the left eye (Fig. 3b). Cerebrospinal fluid (CSF) evaluation showed: 
2.6 cells/mL; protein 61.9 mg/dL; glucose 60 mg/dL. CSF cultures were 
negative for bacteria and fungi. 
Treatment with amphotericin B deoxycholate (total dose: 230 mg), 
was interrupted due to severe pancytopenia (hemoglobin 5.2 g/dL; 
leukocytes 400 cells/µL; neutrophils 0 cells/µL; platelets 86,000/µL). 
Fig. 1 - Case 1: (a) Pre-lobectomy chest x-ray shows a large cavity-contained aspergilloma 
in the right upper lung lobe; (b) CT thorax showing signs of air crescent and invasion of 
pulmonary parenchyma and pleura.
Fig. 2 - Case 1: (a) Post-lobectomy thoracic CT showing bilateral pulmonary invasion by 
Aspergillus; (b) MRI spine showing vertebral and intervertebral disk destruction at the T4 
to T6 level.
Fig. 3 - Case 2: (a) Pre-treatment thoracic CT showing thickened wall cavity and peripheral 
aspergilloma; (b) Pre-treatment MRI brain showing bilateral cerebral hemisphere lesions 
and central cavitation.
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A bone marrow biopsy showed aplasia. At that time, zidovudine was 
replaced with abacavir, and the patient received granulocyte colony 
stimulating factor (G-CSF) and red blood cell transfusions. Voriconazole 
P.O. 400 mg daily was added to replace amphotericin B. His left eye 
was enucleated. The patient improved clinically and laboratory values 
demonstrated medullar recovery (hemoglobin 11.3 g/dL; leucocytes 
7000 cells/µL; neutrophils 2800 cells/µL; platelets 356,000 cells/µL) 
and immunologic recovery (CD4+ count 721 cells/µL). HIV1 viral load 
was less than 50 copies/mL. After 30 days of voriconazole, the patient 
was switched to itraconazole (600 mg orally daily) for eight months. 
Thoracic MRI showed a residual nodular area in the right upper lung 
(Fig. 4a). Brain MRI showed a liquid-filled cavity in the parietal region 
of the brain (Fig. 4b).
DISCUSSION
These cases of subacute invasive infection are characteristic of 
Aspergillus in the setting of AIDS. In case 1, a primary lung aspergilloma 
was initially misdiagnosed as tuberculosis. Mycetoma formation with 
invasion of adjacent pulmonary tissue occurred during treatment with anti-
tuberculosis drugs. Temporary improvement following antifungal therapy 
and surgery was followed by Aspergillus recurrence, dissemination to the 
vertebral column and spinal medulla, and eventual death.
The second patient, who presented with neurological symptoms, was 
initially misdiagnosed with neurotoxoplasmosis. Brain lesions worsened 
and lung lesions and endophthalmitis appeared despite sulfadiazine and 
pyrimethamine treatment. Although the patient lost the infected eye, he 
survived due to antifungal treatment and granulocyte and lymphocyte 
recovery.
AIDS patients infected with Aspergillus experience prolonged 
immunosuppression and higher numbers of opportunistic infections than 
AIDS patients without aspergillosis26. Predisposing factors in invasive 
aspergillosis include neutropenia, pneumocystosis and other pulmonary 
diseases, broad spectrum antibiotic therapy, use of corticoids or 
marijuana, and alcoholism15,21. In these two cases, Aspergillus infections 
were facilitated by low CD4+ cell counts and prolonged neutropenia 
resulting from antiretroviral and antiparasitic drug use. 
It is interesting to note that aspergillosis can manifest clinically 
following resolution of neutropenia (regardless of HIV status)14,22. The 
presence of cytomegalovirus, incidentally found in the lung of the first 
patient, has also been implicated in the development of pulmonary 
aspergillosis18,26.
Most AIDS patients develop acute invasive pulmonary aspergillosis, 
with rapid evolution and hematogenous spread. In some AIDS patients 
aspergillosis may have a subacute or chronic course18, as observed in the 
cases reported here. It is possible that absolute neutrophil counts greater 
than 500 cells/µL and preserved capacity of recuperation of the bone 
marrow protect patients from an acute development of aspergillosis. In 
immunocompetent persons, Aspergillus often presents as an aspergilloma. 
However, this is infrequent in AIDS patients. When they do occur, 50% 
of lesions progress rapidly to invasive pulmonary disease, which is 
associated with a poor prognosis4,12,23. Respiratory symptoms and fever 
are more common in Aspergillus infection in AIDS than in patients 
without HIV infection1.
Positive cultures for Aspergillus spp. in respiratory secretions 
may be considered in AIDS patients with pulmonary infiltrates but 
aspergillosis diagnosis may requires additional invasive techniques12. 
Identification of Aspergillus fumigatus in the first patient’s sputum 
samples and isolation of Aspergillus sp. in the second patient’s eye 
alerted the clinician to the diagnosis of aspergillosis. A. fumigatus is the 
most common species causing human disease6. The presence of serum 
antibodies to Aspergillus may aid in diagnosis of some HIV-infected 
patients, but immunocompromised persons may not have detectable 
antibody levels3.
The death of the first patient highlights the poor response to treatment 
and high lethality characteristic of aspergillosis in the setting of AIDS15. In 
that patient, it is possible that itraconazole plasma levels were depressed 
by concurrent administration of rifampicin. Regardless, the persistence of 
A. fumigatus following prolonged amphotericin B therapy illustrates the 
difficulty in obtaining mycologic cures in immunosuppressed patients. 
The second patient was cured by the treatment with voriconazole followed 
by consolidation therapy with itraconazole. It is believed that highly 
active voriconazole, in combination with immunologic and hematologic 
recovery were responsible for this patient’s survival21. Voriconazole and 
other new antifungals may improve outcomes for HIV and Aspergillus 
co-infected patients in the future10,11.
Opportunistc aspergillosis complicating AIDS patients presents 
a diagnostic and therapeutic dilemma because of its peculiar clinical 
characteristics and unfavorable evolution. Clinical suspicion of 
Aspergillus infection should be accompanied by rapid diagnostic 
evaluation using microscopy, culture, and invasive procedures if 
necessary. Early recognition and detection are essential for timely 
initiation of potentially life-saving antifungal therapy and of drugs for 
phagocytosis and cellular immunity recovery.
RESUMO
Aspergiloma primário e aspergilose invasiva subaguda em dois 
pacientes com AIDS
A aspergilose invasiva em pacientes com aids, embora incomum, é 
relevante pela apresentação clínica peculiar e alta letalidade. Este relato 
descreve os casos de dois pacientes com aids com grave imunossupressão 
Fig. 4 - Case 2: a) Thoracic MRI showing residual nodule following treatment; (b) Post-
treatment MRI brain demonstrates a parietal cavity signal intensity similar to CSF. Areas of 
gliosis and accentuated groves are noted in the adjacent cerebral parenchyma.
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celular e neutropenia prévia, os quais tiveram aspergiloma pulmonar 
primário, com disseminação para mediastino, vértebras e medula espinhal, 
evoluindo para óbito apesar do tratamento antifúngico. O segundo 
paciente, que tinha lesões cavitárias múltiplas no cérebro e infecção ocular 
e pulmonar, recuperou-se após tratamento com voricanazol, itraconazol 
e com drogas para aumentar o número de neutrófilos e de linfócitos 
CD4+. Estes casos demonstram o risco de infecção por Aspergillus após 
episódios de neutropenia em pacientes com aids e alertam para o início 
precoce de terapia antifúngica eficaz.
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